WD Rutherford LLC Has $833,000 Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

WD Rutherford LLC trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 25.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,635 shares of the healthcare conglomerate’s stock after selling 550 shares during the period. WD Rutherford LLC’s holdings in UnitedHealth Group were worth $833,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Bell Investment Advisors Inc lifted its holdings in UnitedHealth Group by 4.8% in the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after buying an additional 24 shares during the period. Harbor Investment Advisory LLC lifted its holdings in UnitedHealth Group by 3.2% in the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after buying an additional 1,129 shares during the period. Austin Private Wealth LLC lifted its holdings in UnitedHealth Group by 9.8% in the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after buying an additional 111 shares during the period. Vanguard Personalized Indexing Management LLC increased its stake in UnitedHealth Group by 7.9% in the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 75,602 shares of the healthcare conglomerate’s stock valued at $39,802,000 after purchasing an additional 5,537 shares in the last quarter. Finally, Capital Insight Partners LLC increased its stake in UnitedHealth Group by 3.8% in the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after purchasing an additional 332 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Up 1.0 %

NYSE:UNH traded up $5.79 during mid-day trading on Friday, hitting $584.51. 2,376,416 shares of the company’s stock were exchanged, compared to its average volume of 3,156,778. The company has a 50 day simple moving average of $537.83 and a 200-day simple moving average of $509.89. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $591.54. The firm has a market capitalization of $539.75 billion, a P/E ratio of 35.73, a PEG ratio of 1.61 and a beta of 0.59.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.14 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.44%. UnitedHealth Group’s payout ratio is presently 51.34%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. JPMorgan Chase & Co. upped their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Argus increased their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Wednesday. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research report on Monday, August 19th. Finally, Wells Fargo & Company raised their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.